Cardiovascular disease supplements refer to nutritional products designed to complement traditional approaches in managing cardiovascular health. These supplements typically contain a variety of vitamins, minerals, antioxidants, and other bioactive compounds that are believed to support heart health. Common cardiovascular disease supplements include omega-3 fatty acids, coenzyme Q10 (CoQ10), magnesium, vitamin D, and various antioxidants such as vitamin C and E. Omega-3 fatty acids, found in fish oil supplements, are often associated with reducing triglycerides and inflammation, while CoQ10 plays a role in cellular energy production. These supplements are commonly taken by individuals aiming to enhance their cardiovascular health, either as part of preventive measures or in conjunction with prescribed medications. It's crucial for individuals considering cardiovascular disease supplements to consult with healthcare professionals, as the effectiveness and safety of these supplements may vary, and potential interactions with medications should be carefully evaluated.
Title : Revolutionizing CKD care: How finerenone transforms outcomes in heart and kidney health - Insights from fidelio-DKD
Robert J Chilton, University of Texas Health Science Center San Antonio, United States
Title : Novel important cellular responses, signaling mechanisms and therapeutic options for pulmonary hypertension and right heart failure
Yong Xiao Wang, Albany Medical Center, United States
Title : Preventing sports-related cardiac arrest: Coronary artery calcium scoring stratifies the benefit of low-dose aspirin use for risk reduction
Arthur J Siegel, Massachusetts General Hospital, United States
Title : TED2HOME - A low cost automatic external defibrillator for home/office
Abraham Teddy Weiss, Hadassah University Hospital, Israel
Title : Subclinical atherosclerosis: Association with additional risk factors and somatic diseases
Mekhman N Mamedov, National Research Center for Preventive Medicine, Russian Federation
Title : Novel ways of cardiovascular risk assessment
Syed Raza, Awali Hospital, Bahrain